jueves, 12 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 14, 2026

Wells Fargo & Company Q4 Earnings Call Highlights

View original at finance.yahoo.com
Wells Fargo & Company Q4 Earnings Call Highlights Wells Fargo & Company logo Key Points Wells Fargo reported strong 2025 results with $21.3 billion net income (EPS up 17%) and returned $23 billion to shareholders (13% dividend increase and $18 billion of buybacks), but expects buybacks to be lower in 2026 as it pursues…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • On potential credit card rate cap it is 'too early to know' what actions may be taken by policymakers

    80% confidence
  • Wells Fargo increased trading-related assets by 50% in 2025 to support customer trading flows and financing activities

    80% confidence
  • Average loans and average deposits expected to grow mid-single digits from Q4 2025 to Q4 2026

    80% confidence
  • Share repurchases are expected to be lower in 2026 given opportunities for organic growth

    80% confidence
  • 2026 non-interest expense is forecast at approximately $55.7 billion

    80% confidence
  • Guidance assumes two to three Fed rate cuts in 2026 and relatively stable 10-year Treasury rates

    80% confidence
  • Period-end loans rose 5% from Q3, the strongest linked-quarter growth since Q1 2020

    80% confidence
  • The Fed's removal of the asset cap is 'a pivotal moment'

    80% confidence
  • Markets NII is expected to rise to approximately $2 billion in 2026

    80% confidence
  • Target CET1 range is approximately 10% to 10.5%

    80% confidence
  • 2026 total net interest income is expected to be approximately $50 billion, plus or minus

    80% confidence
  • Demand remains solid in several commercial real estate subsectors, while office valuations have stabilized

    80% confidence
  • Early vintages from newer credit card products are beginning to contribute to profitability after two to three years of upfront costs

    80% confidence
  • Wells Fargo's goal is to become a top-five U.S. investment bank

    80% confidence
  • Expects approximately $2.4 billion of gross expense reductions in 2026 from efficiency initiatives

    80% confidence
  • 2025 results reflected 'significant momentum' across the company

    80% confidence
  • The increase in non-performing assets was borrower-specific and not indicative of systemic weakness

    80% confidence
  • Credit performance remained 'strong'

    80% confidence
  • Deal pipeline entering 2026 was 'meaningfully greater' than at any point in the last five years

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,565 documentos fuente archivados
Consulta estos datos → isubstrate.com
Wells Fargo & Company Q4 Earnings Call Highlights — Source | Via News | es.VIA.NEWS